Publication:
Expression of Plakophilins (Pkp1, Pkp2, and Pkp3) in Gastric Cancers

dc.authorscopusid36702709300
dc.authorscopusid22945639700
dc.authorscopusid15033172700
dc.authorscopusid19640258900
dc.authorscopusid7003323947
dc.contributor.authorDemirag̈, G.G.
dc.contributor.authorSüllü, Y.
dc.contributor.authorGürgenyataǧi, D.
dc.contributor.authorOkumus̈, N.
dc.contributor.authorYücel, I.
dc.date.accessioned2020-06-21T14:41:21Z
dc.date.available2020-06-21T14:41:21Z
dc.date.issued2011
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Demirag̈] Güzin Gonullu, Department of Medical Oncology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Süllü] Yurdanur Demirel, Department of Pathology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Gürgenyataǧi] Dilek, Department of Medical Oncology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Okumus̈] Nilgün Özbek, Department of Radiation Oncology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yücel] Idris, Department of Medical Oncology, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractBackground: The importance of cell-cell junction proteins (including armadillo proteins) in tumor biology is known, but limited with regard to plakophilins. We explored the relationship between plakophilins (PKP1, PKP2, PKP3) to gastric cancer via immunohistochemical techniques.Methods: We compared the immunohistochemistry of PKPs in 34 gastric adenocarcinomas and 20 normal gastric tissues.Results: In gastric cancer, PKP1 expression was unchanged but PKP2 and PKP3 were significantly decreased as compared to normal controls. There was no observable clinical association with PKP1 or PKP2 expression; however, low PKP3 level and poor prognosis appeared to correlate with regards to node number and tumor stage. The mean disease-free survival (DFS) was 38 ± 3 months (range: 32 - 44) and mean overall survival (OS) 42 ± 4 months (range: 38 - 50). Decreased PKP2 appeared to negatively impact DFS.Conclusion: Decreased PKP2 and PKP3 may be early prognostic markers and loss of PKP3 expression during gastric carcinoma progression may indicate an invasive phenotype. © 2011 Demirag et al; licensee BioMed Central Ltd.en_US
dc.identifier.doi10.1186/1746-1596-6-1
dc.identifier.issn1746-1596
dc.identifier.issue1en_US
dc.identifier.pmid21194493
dc.identifier.scopus2-s2.0-78650668359
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1186/1746-1596-6-1
dc.identifier.volume6en_US
dc.identifier.wosWOS:000286523500001
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherBMCen_US
dc.relation.ispartofDiagnostic Pathologyen_US
dc.relation.journalDiagnostic Pathologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleExpression of Plakophilins (Pkp1, Pkp2, and Pkp3) in Gastric Cancersen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files